Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species by dos Santos, Jessica Cristina et al.
RESEARCH ARTICLE
Cytokines and microbicidal molecules
regulated by IL-32 in THP-1-derived human
macrophages infected with New World
Leishmania species
Je´ssica Cristina dos Santos1,2, Bas Heinhuis1, Rodrigo Saar Gomes2, Michelle S. M.
A. Damen1, Fernando Real3, Renato A. Mortara3, Samuel T. Keating1, Charles
A. Dinarello1,4, Leo A. B. Joosten1, Fa´tima Ribeiro-Dias2*
1 Department of Internal Medicine and Radboud Center of Infectious Diseases (RCI), Radboud University
Medical Center, Nijmegen, The Netherlands, 2 Instituto de Patologia Tropical e Sau´de Pu´blica, Universidade
Federal de Goia´s, Goiaˆnia, Brazil, 3 Departamento de Microbiologia, Imunologia e Parasitologia, Escola
Paulista de Medicina, Universidade Federal de São Paulo, Brazil, 4 School of Medicine, Division of infectious
diseases, University of Colorado Denver, Aurora, Colorado, United States of America
* fatimardias@gmail.com
Abstract
Background
Interleukin-32 (IL-32) is expressed in lesions of patients with American Tegumentary Leish-
maniasis (ATL), but its precise role in the disease remains unknown.
Methodology/Principal findings
In the present study, silencing and overexpression of IL-32 was performed in THP-1-derived
macrophages infected with Leishmania (Viannia) braziliensis or L. (Leishmania) amazonen-
sis to investigate the role of IL-32 in infection. We report that Leishmania species induces
IL-32γ, and show that intracellular IL-32γ protein production is dependent on endogenous
TNFα. Silencing or overexpression of IL-32 demonstrated that this cytokine is closely
related to TNFα and IL-8. Remarkably, the infection index was augmented in the absence of
IL-32 and decreased in cells overexpressing this cytokine. Mechanistically, these effects
can be explained by nitric oxide cathelicidin and β-defensin 2 production regulated by IL-32.
Conclusions
Thus, endogenous IL-32 is a crucial cytokine involved in the host defense against Leish-
mania parasites.
Author summary
Leishmania (V.) braziliensis and L. (L.) amazonensis are protozoa that infect macrophages
and cause cutaneous and mucosal leishmaniasis. Here we showed that both Leishmania
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species induce the production of IL-32γ in human macrophages. This intracellular and
pro-inflammatory cytokine mediates the production of cytokines, especially TNFα and
IL-8, in Leishmania-infected macrophages. Differential effects of IL-32γ on TNFα, IL-10
and IL-1Ra production after infection with distinct Leishmania species were detected,
consistent with the concept that IL-32γ can differently influence the outcome of inflam-
matory process in leishmaniasis lesions. Moreover, IL-32γ upregulates microbicidal mole-
cules, antimicrobial peptides, as well as NO, which are known as important factors in
parasite control. These results underscore IL-32γ as a crucial cytokine to host defense
against leishmaniasis.
Introduction
Interleukin-32 (IL-32) is a predominantly intracellular proinflammatory cytokine [1] that can
be expressed in nine different isoforms (IL-32α, IL-32β, IL-32γ, IL-32δ, IL-32ε, IL-32z, IL-32η,
IL-32θ and IL-32σ) [2]. This cytokine can induce production of tumor necrosis factor alpha
(TNFα), IL-8, IL-6, and IL-1β in THP-1 and RAW264.7 macrophages cell lines [3,4], with IL-
32γ being the most active isoform [5].
Induction of IL-32α and IL-32γ during Mycobacterium tuberculosis (MTB) infection medi-
ates TNFα, IL-6, IL-1β production and macrophage apoptosis that is involved in protection
against MTB [6,7]. In addition, IL-32/vitamin D/antimicrobial peptides axis control MTB
infection [8]. IL-32 is associated with strong Th1 immune response, controlling M. leprae
infection [9]. In viral infections, induction of IL-32 is associated with the control of viral repli-
cation [10–12], but also with inflammation and tissue lesion [13–16]. In protozoan infections,
IL-32 has been identified in lesions of patients with American Tegumentary Leishmaniasis
(ATL) [17].
ATL is a vector-borne disease caused by Leishmania parasites. In general, L. (Viannia) bra-
ziliensis cause localized cutaneous (LCL) and oral/ nasal mucosal lesions (ML). LCL can cure
spontaneously or after treatment. By contrast ML does not spontaneously heal and recurrence
is frequent after treatment. In addition to these clinical forms, L. (Leishmania) amazonensis
can cause diffuse cutaneous leishmaniasis (DCL), which it is not cured even after treatment
[18–20]. A moderate or strong Th1 response is present in infections caused by L. (V.) brazilien-
sis whereas patients infected with L. (L.) amazonensis present a less potent Th1-type response
or can be anergic [21]. The strong Th1-type immune response is important for controlling the
infection but also causes inflammation and pathology [22,23]. Th1-type cytokines (IFNγ and
TNFα) activate infected monocytes or macrophages to secrete microbicidal molecules such as
oxygen and nitrogen reactive species, which are crucial for the parasite killing [24–28]. During
Leishmania infection, macrophages can produce proinflammatory cytokines (TNFα, IL-1β,
IL-8) and regulatory (IL-10, IL-1Ra) molecules [29–31]. Thus a balance between pro- and
anti-inflammatory mediators during the immune responses is critical to control inflammatory
diseases [32,33].
The mechanisms responsible for persistence of the parasite and immunopathology of leish-
maniasis remain unclear. We previously reported that IL-32γ is expressed in cutaneous and
mucosal lesions of patients with ATL caused by Leishmania (Viannia) species and also that L.
(V.) braziliensis induces IL-32γ in peripheral blood mononuclear cells (PBMC) [17]. Here, we
investigated whether distinct isoforms of IL-32 can be induced by L. (V.) braziliensis and L.
(L.) amazonensis, and whether IL-32 can regulate cytokine and microbicidal activity of human
macrophages infected with these two New World Leishmania species.
IL-32 in Leishmania macrophage infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005413 February 27, 2017 2 / 21
doctors, fellows of CNPq. BH is supported by a
grant from the Dutch Arthritis Foundation (13-3-
302). The funders had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Methods
Ethics statement
The study used only cell lines and parasites. The whole project was approved by Ethical Commi-
tee of Hospital das Clı´nicas/Universidade Federal de Goia´s, Brazil, prot. n. 44033514.0.0000.5078.
THP-1 cell line and Leishmania cultures
THP-1 cell line was obtained from ATCC (Manassas, VA). Cells were cultured in RPMI-1640
medium (Gibco—Life Technologies) supplemented with 10% heat-inactivated fetal bovine
serum (FBS; Gibco—Life Technologies), 10 mM of pyruvate, 10 mM L-glutamine, 100 U/mL
of penicillin and 100 μg/mL streptomycin (Sigma—Aldrich).
L. (L.) amazonensis (IFLA/BR/67/PH8) reference strain and MHOM/BR/2003/IMG L. (V.)
braziliensis, a clinical isolate obtained from cutaneous lesion of LCL patient (Leishbank IPTSP/
UFG) [34], were used. Promastigotes forms were cultured in Grace’s Insect Medium, (Gibco—
Life Technologies) supplemented with heat-inactivated 20% FBS (Sigma—Aldrich) and 100
U/mL of penicillin/streptomycin (Sigma—Aldrich) at 26˚C. Parasites of L. (L.) amazonensis
from stationary phase (6th—7th day) of growth were used to infect macrophages derived from
THP-1 cells. For L. (V.) braziliensis, parasites were collected from stationary phase (6th—7th
day) of growth and metacyclic promastigotes were negatively selected using Bauhinia purpurea
lectin according to the protocol described by [35]. Parasites were washed three times with ster-
ile phosphate-buffered saline (PBS) pH 7.4 (1,000 g, 10 min, 10˚C). The suspensions were
diluted into 0.4% formaldehyde in PBS for parasite quantification by hemocytometer.
THP-1-derived macrophages and stimulation
A previously described protocol [36] was used for THP-1 cell differentiation into macrophages
with some alterations. According to the type of experiment, cell numbers were adapted to cul-
tures with or without cover slides. Briefly, cells were cultured with phorbol myristate acetate
(PMA, Sigma-Aldrich) at 100 ng/mL. After 48 h (37˚C, 5% CO2), cells were gently washed
with warm medium and incubated for an additional 48 h. Medium was replenished and cells
were incubated for a further 24 h. Parasites (at multiplicity of infection (MOI) ~ 5:1) of both
Leishmania species were added into the THP-1-derived macrophage cultures and 100 ng/mL
of E. coli LPS (O111:B4 Sigma-Aldrich) was used as a control. This commercial LPS was
further purified based on [37]. In some experiments, THP-1-derived macrophages were prein-
cubated for 1 h in the absence or presence of neutralizing antibodies to TNFα (5 μg/mL, Adali-
mumab) or IgG control (5 μg/mL). After 4 h, non-internalized parasites were washed out,
medium was replaced and cultures were incubated for indicated times.
Confocal microscopy
After THP-1-derived macrophage infection (2 x 105 cells/0.5 mL, grown over coverslips in
24-wells plates; MOI: 5:1; 24 h), cells were fixed with 4% paraformaldehyde and blocked/per-
meabilized with 0.1% saponin, 10% FBS, 5% goat serum and 5% human serum solution (block
solution). Primary antibodies to IL-32 (rabbit polyclonal antibody 5 μg/mL; Abcam;) and to
LAMP1 (mouse H4B4, IgG1; 1/2 culture supernatants; to identify lysosomal proteins and para-
sitophorous vacuoles); secondary antibodies—Alexa Fluor 594 goat anti-rabbit IgG (H+L), 1/
200, to detect IL-32 (Molecular Probes) and anti-mouse IgG (whole molecule) F(ab)´2 frag-
ment of sheep antibody-Cy3 conjugate, 1/200, to detect LAMP2 (Sigma-Aldrich); and control
antibodies were all in block solution. A solution of 4´,6-diamidino-2-phenylindole (DAPI;
10 μg/mL; Invitrogen, Life Technologies) was used to stain nucleus/DNA, and fluorescent
IL-32 in Leishmania macrophage infection
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mounting medium (Dako) was used to prepare the coverslips for confocal microscopy. Images
were acquired in a Leica TCS SP5 II confocal microscope.
Silencing and overexpression of IL-32 by siRNA or plasmid
THP-1 cells (15 x 106 cells/15 mL) were differentiated into macrophages (75 cm2—tissue cul-
ture flask; Corner) for 5 days, as described above. 2.5 x 106 cells/800 μL were electroporated by
using Amaxa Nucleofector technology (Lonza, Basel) according with the protocol described in
reference [38]. For knockdown of IL-32, 1 μg of ON-TARGETplus SMARTpool siRNA (S1
Table) per transfection was used or 1 μg of ON-TARGETplus SMARTpool control siRNA
(Dharmacon Inc). For IL-32 overexpression, 0.5 μg of pCDNA3 plasmid expressing human
IL-32γ or egfp was used as a control. Transfected cells (3 x 105/100 μL) were plated on to flat-
bottom 96-well plates (Costar) with or without 6 mm coverslips and 100 μL of transfection
medium were added. Twenty-four hours post-transfection, the medium was replaced and 1.5
x 106 parasites of either Leishmania species were added to the cultures. After 4 h and 24 h,
supernatants were collected and stored at -20˚C until cytokine measurement; after 4 h, 24 h or
48 h the cell monolayers were collected by adding 200 μL of TRIzol and stored at -80˚C until
mRNA extraction. After incubation, coverslips were collected to measure macrophage infec-
tion index. We performed comparable experiments to determine transfection (egfp) efficiency
and this was around 30%. It is important to notice that according to the protocol used for
silencing and overexpression [38], the general protocol described above needed alterations.
After derivation with PMA, cells were transfected and they rested 24 h in medium containing
5% and 20% of human serum for silencing and overexpression, respectively. In addition, to
keep cells adhered additional PMA was added to the cultures (2.5 ng/mL). Thus, the results are
comparable among them only in each set of experiments in the same conditions (WT cells vs
transfected cells).
mRNA expression by quantitative real-time PCR (qPCR)
RNA isolation was carried out based on the method reported by [39]. RNA was precipitated
with isopropanol and washed with 75% ethanol followed by reconstitution in RNAse-free
water. Subsequently, RNA was reverse transcribed into cDNA by using iScript (Bio-Rad, Her-
cules, CA, USA). Diluted cDNA was used for qPCR analysis that was done by using the StepO-
nePlus sequence detection systems (Applied Biosystems, Foster City, CA, USA) with SYBR
Green Mastermix (Applied Biosystems). Primer sequences (S2 Table) for IL-32 were previ-
ously developed by [3,40] whereas other primer sequences (TNFα, IL-1β, IL-8, IL-1Ra, IL-10,
inducible nitric oxide synthase [iNOS], cathelicidin, b-defensin) were obtained from Harvard
Primerbank database. Primers were purchased from Biolegio. The mRNA analysis was done
with the 2^dCt x 1000 method and normalized against the housekeeping gene GAPDH.
Assessment of Leishmania-induced mediators
Human TNFα, IL-8, IL-1β, IL1-Ra, IL-10 and LL-37 (cathelicidin) were determined in culture
supernatants using commercial Enzyme-Linked Immunosorbent Assay (ELISA) kits (Sanquin,
R&D Systems and Hycult biotech). Intracellular IL-32 protein was measured in cell lysates col-
lected with Triton-X100 by using an IL-32 ELISA (R&D Systems). Nitric Oxide (NO) produc-
tion was determined in culture supernatants with Griess reagent to detect nitrite (Sigma-
Aldrich). Cell death was monitored by measuring the release of lactate dehydrogenase (LDH)
in the supernatants by using a Cytotox 96 kit (Promega).
IL-32 in Leishmania macrophage infection
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Evaluation of macrophage infection
After incubation, the coverslips were collected, fixed and stained with Giemsa (Merck Milli-
pore) and analyzed under a light microscope (1000x) to determine the infection index. Three
hundred cells were analysed and the percentage of infected cells and the mean number of
intracellular parasites per infected cell were determined. Infection index = percentage of
infected cells × mean number of parasites per infected cell.
Statistical analysis
Data represent mean ± SEM (standard error of the mean). All data were evaluated by OneWay
ANOVA/Bonferroni test using GraphPad Prism v.6 software (San Diego, CA, USA). Level of
significance was established at p< 0.05.
Results
Leishmania-induced intracellular IL-32γ production is dependent on
TNFα
We detected a significant induction of IL-32γ, but not IL-32β or IL-32α for both L. (L.) ama-
zonensis or L. (V.) braziliensis infection (24 h; Fig 1A). L. (L.) amazonensis induced higher
IL-32γ expression than L. (V.) braziliensis (Fig 1A). IL-32γ time course showed that IL-32γ
mRNA started to increase after 4 h and achieved a peak at 24 h (S1A Fig—left panel). It is
known that IL-32γ mRNA can be spliced into IL-32β and IL-32α [3]. Here we showed
that in THP-1 cultures Leishmania, in contrast to LPS, only induced IL-32γ (Fig 1A and S1A
Fig—right panel). The intracellular IL-32 protein levels (Fig 1B), paralleling changes in
mRNA expression, were higher in L. (L.) amazonensis than in L. (V.) braziliensis-infected
macrophages.
Both L. (L.) amazonensis and L. (V.) braziliensis induced significant amounts of TNFα, IL-
8, IL-1Ra and IL-10. Time course production of these cytokines showed that 24 h was the best
cutoff point to establish relationship between these cytokines and IL-32 production (S2 Fig).
TNFα levels were increased after 24 h of infection with both species (Fig 1C) and were higher
than TNFα produced after 4 h, whereas LPS–induced TNFα production declined from 4 h to
24 h (S1B Fig). Remarkably, only L. (V.) braziliensis induced a major increase in IL-1β produc-
tion. L. (L.) amazonensis induced considerably higher levels of TNFα, IL-1Ra and IL-10 than
L. (V.) braziliensis (Fig 1C).
Since Leishmania-induced IL-32 and TNFα showed similar time course production
(increase from 4 h to 24 h), to explore the influence of Leishmania-induced TNFα in the pro-
duction of IL-32, TNFα was efficiently blocked using specific antibodies during Leishmania
species infection (Fig 1D, left panel), leading to a significant reduction in intracellular IL-32
production (Fig 1D, right panel). Comparable results were obtained when LPS was used to
induce TNFα (Fig 1D, left panel) and IL-32 (Fig 1D, right panel). Increased intracellular IL-
32γ concentrations are associated with cell death [41]. However we observed LDH concentra-
tions remained stable following Leishmania infection (S1C Fig).
Next we investigated the cellular distribution of IL-32 after Leishmania species infection. In
Fig 2A is depicted general staining for IL-32 in uninfected or Leishmania-infected cells. As
showed in Fig 2B IL-32 localizes to both the cytoplasm and nucleus of macrophages. In some
preparations, IL-32 co-localized with lysosomes, however co-localization with Leishmania con-
taining parasitophorous vacuoles was rare (Fig 2C).
IL-32 in Leishmania macrophage infection
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Silencing or overexpression shows that IL-32γ regulates cytokine
production induced by Leishmania species
We investigated whether endogenous IL-32 is directly involved in the enhanced production of
pro- and anti-inflammatory cytokines observed after Leishmania infection. To verify whether
Fig 1. Leishmania induces IL-32γ expression in a TNFα-dependent manner. PMA-differentiated THP-1 cells (1 x 106 cells/mL) were infected with
promastigote forms (5 x 106 parasites) in the growth stationary phase of L. (L.) amazonensis (L. amaz), metacyclic promastigote forms (5 x 106 parasites)
of L. (V.) braziliensis (L. braz) or LPS (100 ng/mL) as a positive control during 4 h. Cells were washed to remove non-internalized parasites and incubated
for 24 h. (A) mRNA expression of isoforms α, β and γ of IL-32 was determined by quantitative real-time PCR. (B) Intracellular IL-32 protein levels were
determined by ELISA in cell lysates. (C) TNFα, IL-8, IL-1β, IL-1Ra, IL-10 productions were determined by ELISA in culture supernatants. (D) Antibodies to
TNFα (anti-TNFα, 5 μg/ml) or isotype control (5 μg/mL) were added 30 min before addition of LPS (100 ng/mL) or Leishmania sp. TNFα levels (left panel)
and intracellular IL-32 (right panel) were determined by ELISA in supernatants and cell lysates, respectively. Values are expressed as means ± SEM of
three independent experiments. *p < 0.05 (Medium vs LPS, L. amaz, L. braz); #p < 0.05 (L. amaz, L. braz).
doi:10.1371/journal.pntd.0005413.g001
IL-32 in Leishmania macrophage infection
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Fig 2. Intracellular distribution of IL-32 after Leishmania species infection. PMA-differentiated THP-1 cells (2 x 105 cells/0.5 mL) were infected with
promastigote forms (10 x 105 parasites) in stationary phase of growth of L. (L.) amazonensis or metacyclic promastigote forms (10 x 105 parasites) of L. (V.)
braziliensis during 4 h. Afterwards, cells were washed to remove non-internalized parasites and incubated for 24 h. Cells were stained for IL-32 (rabbit
polyclonal antibody; red), lysosomal-associated membrane protein, LAMP1 (mouse monoclonal antibody; green) and dapi (blue) for confocal microscopy.
Yellow colour indicates colocalization of IL-32 and LAMP1. (A) In the eight first images, bar = 20 μm; two inferior images, bar = 10 μm (L. (V.) braziliensis). (B)
L. (L.) amazonensis, white arrow heads indicate parasites present in LAMP1+-parasitophorous vacuoles; bar = 10 μm; (C) L. (V.) braziliensis, white arrow
heads indicate colocalization of IL-32 and LAMP1 in a LAMP1+-parasitophorous vacuole containing one amastigote (blue), bar = 1 μm; images were took
from (A) (left bottom, dashed white squares).
doi:10.1371/journal.pntd.0005413.g002
IL-32 in Leishmania macrophage infection
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the transfection procedure may interfere in the capacity of THP-1-derived macrophages to
produce cytokines, cells without transfection (WT THP-1) were also investigated. IL-32
mRNA expression (all IL-32 isoforms and IL-32γ) was silenced by RNA interference (Fig 3A).
Silencing of endogenous IL-32γ decreased TNFα mRNA expression at 24 h (p< 0.05), but not
TNFα protein levels (Fig 3B). In addition, after 4 h neither the TNFα mRNA nor the protein
was significantly affected by silencing of IL-32 (S3A Fig). Both IL-8 mRNA and IL-8 protein
were strongly reduced after infection with either Leishmania species when IL-32 was silenced
(Fig 3B). Interestingly, when IL-32 expression was silenced, the levels of induced IL-1β and IL-
1Ra mRNA and protein expression induced by L. (V.) braziliensis were not altered (Fig 3C). By
contrast, IL-1Ra mRNA and IL-1Ra protein were decreased after infection with L. (L.) amazo-
nensis and silencing of IL-32 (Fig 3C). No differences were observed for IL-10 mRNA expres-
sion and protein production for both Leishmania species in IL-32 knockdown cells (Fig 3D).
Overexpression of IL-32γ (Fig 4A) resulted in significant increases in TNFα and IL-8
mRNA expression and protein production after infection with either Leishmania species in
comparison with egfp transfected control cells (Fig 4B). The presence of high levels of IL-32γ
caused an impressive increase of TNFα mRNA fast after 4 h of incubation without significant
alteration in protein levels (S3C Fig). In accordance with IL-32γ silencing results, no differ-
ences in IL-1β levels were observed whereas increased IL-1Ra mRNA and protein expression
was detected only after infection with L. (L.) amazonensis (Fig 4C). No differences were found
between the two Leishmania species on IL-10 mRNA expression and proteins levels (Fig 4D).
IL-32γ regulates nitric oxide and cathelicidin production, microbicidal
molecules that can control Leishmania species infection
To examine if endogenous IL-32γ controls Leishmania species infection, IL-32 was silenced in
THP-1-derived macrophages prior to infection. To verify whether the transfection procedure
may interfere with the capacity of THP-1-derived macrophages uptake of Leishmania, cells
without transfection (WT THP-1) were also investigated. A significant increase in the percent-
age of macrophages infected with either L. (L.) amazonensis or L. (V.) braziliensis was observed
after 4 h, 24 h and 48 h in the absence of IL-32 (Fig 5A and 5B). However, no differences were
observed in the number of parasites per infected cell (Fig 5A and 5B). The infection index with
both Leishmania species (4 h; 24 h) was increased in IL-32 knockdown cells (Fig 5A and 5B).
Because silencing of IL-32 is a transitory process, we checked for IL-32 expression 48 h after
infection. Indeed IL-32 silencing was reversed at this time (S4 Fig), potentially explaining the
results at this time point of infection.
Fig 5C shows a significant decrease of iNOS and nitrite production after 24 h of infection
with both Leishmania species in cells silenced for IL-32 compared to control cells. In addition,
cathelicidin and β-defensin 2 mRNA expression as well as antimicrobial peptide LL-37 con-
centration were strongly reduced in THP-1-derived macrophages depleted of IL-32 (Fig 5D
and 5E).
In IL-32γ overexpressing cells, we observed a significant decrease in the percentage of
infected cells and infection index after 4 h and 24 h with both L. (L.) amazonensis and L. (V.)
braziliensis (Fig 6A and 6B). No differences were observed in the number of parasites per L.
(L.) amazonensis- or L. (V.) braziliensis-infected cells (Fig 6B). In contrast, a reduction in the
number of L. (V.) braziliensis parasites per infected cell after 4 h of infection was detected in
IL-32γ-overexpressing cells (Fig 6B). In parallel, we observed a significant increase of iNOS
mRNA expression and nitrite production after 24 h of infection with both Leishmania species
in IL-32γ-transfected cells (Fig 6C). Moreover cathelicidin and β-defensin 2 mRNA expression
IL-32 in Leishmania macrophage infection
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Fig 3. Decrease of cytokine production after IL-32 silencing in THP-1-derived macrophages infected with Leishmania species. PMA-
differentiated THP-1 cells (2.5 x 106 cells/800 μL) were electroporated by using Amaxa Nucleofector Technology with IL-32 siRNA (for IL-32
knockdown) and control siRNA according to the protocol described in [38]. The final concentration per well was 3 x 105 cells/100 μL. After 24 h of
transfection, cells were infected with promastigote forms (1.5 x 106 parasites) in the growth stationary phase of L. (L.) amazonensis (L. amaz) or
metacyclic promastigote forms (1.5 x 106 parasites) of L. (V.) braziliensis (L. braz). After 4 h, non-internalized parasites were washed out and cells were
incubated for 24 h. (A) mRNA expression of IL-32γ isoform and all isoforms were determined by quantitative real-time PCR. mRNA expression and
protein levels of (B) TNFα and IL-8, (C) IL-1β and IL-1Ra and (D) IL-10 were determined by quantitative real-time PCR and ELISA in supernatants,
respectively. Values are expressed as means ± SEM of three independent experiments. *p < 0.05 (Control SiRNA vs IL-32 SiRNA); #p < 0.05 (L. amaz,
L. braz).
doi:10.1371/journal.pntd.0005413.g003
IL-32 in Leishmania macrophage infection
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005413 February 27, 2017 9 / 21
Fig 4. Increased cytokine production after overexpression of IL-32 in human THP-1-derived macrophages infected with Leishmania
species. PMA-differentiated THP-1 cells (2.5 x 106 cells/800 μL) were electroporated by using Amaxa Nucleofector Technology with IL-32 plasmid (for
IL-32 overexpression) and egfp plasmid (as a control) according to the protocol described in [38]. The final concentration per well was 3 x 105 cells/
100 μL. After 24 h of transfection, cells were infected with promastigote forms (1.5 x 106 parasites) in the growth stationary phase of L. (L.)
amazonensis (L. amaz), metacyclic promastigote forms (1.5 x 106 parasites) of L. (V.) braziliensis (L. braz). After 4 h cells were washed and incubated
for 24 h. (A) mRNA expression of IL-32γ isoform and all IL-32 isoforms was determined by quantitative real-time PCR. mRNA expression and protein
levels of (B) TNFα and IL-8, (C) IL-1β and IL-1Ra and (D) IL-10 were determined by quantitative real-time PCR and ELISA in supernatants,
respectively. Values are expressed as means ± SEM of three independent experiments. *p < 0.05 (egpf plasmid vs IL-32γ plasmid); #p < 0.05 (L.
amaz, L. braz).
doi:10.1371/journal.pntd.0005413.g004
IL-32 in Leishmania macrophage infection
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Fig 5. Silencing of IL-32 in human THP-1-derived macrophages increases Leishmania species infection. PMA-differentiated THP-1 cells (2.5 x 106
cells/800 μL) were electroporated by using Amaxa Nucleofector Technology with IL-32 siRNA (for knockdown IL-32) and control siRNA according with
protocol described by [38]. The final concentration of cells per well were 3 x 105 cells/100 μL. After 24 h of transfection, cells were infected with
promastigotes forms (1.5 x 106 parasites) in the growth stationary phase of L. (L.) amazonensis (L. amaz), metacyclic promastigote forms (1.5 x 106
parasites) of L. (V.) braziliensis (L. braz). After 4 h, cells were washed to remove non-internalized parasites and incubated for 24 h or 48 h. Cells were
stained and percentage of infected macrophages, number of parasites per infected cells, and infection index were evaluated. (A) infection with L.
amazonensis; (B) infection with L. braziliensis. iNOS (C—left panel), cathelidicin (D—left panel) and β-defensin 2 (E) mRNA expression were determined
by quantitative real-time PCR (24 h). Production of nitrite (C—right panel) and LL-37 (D—right panel) was determined by Griess reagent and ELISA in
supernatants, respectively (24 h). Values are expressed as means ± SEM of three independent experiments. *p < 0.05 (Control SiRNA vs IL-32 SiRNA).
doi:10.1371/journal.pntd.0005413.g005
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Fig 6. Decreased Leishmania species infection and increased leishmanicidal molecules after IL-32 overexpression in human THP-1-derived
macrophages. PMA-differentiated THP-1 cells (2.5 x 106 cells/800 μL) were electroporated by using Amaxa Nucleofector Technology with IL-32 plasmid
(for IL-32 overexpression) and egfp plasmid (as a control). The final concentration of cells per well were 3 x 105 cells/100 μL. After 24 h of transfection, cells
were infected with promastigote forms (1.5 x 106 parasites) in the growth stationary phase of L. (L.) amazonensis (L. amaz) or metacyclic promastigote
forms (1.5 x 106 parasites) of L. (V.) braziliensis (L. braz). After 4 h, non-internalized parasites were washed out and cells were incubated for 24 h or 48 h.
Cells were stained and percentage of infected macrophages, number of parasites per infected cells, and infection index were evaluated. (A) infection with L.
amazonensis; (B) infection with L. braziliensis. iNOS (C—left panel) and cathelidicin (D—left panel) and β-defensin 2 (E) mRNA expression were
determined by quantitative real-time PCR (24 h). Nitrite production (C—right panel) and LL-37 production (D—right panel) were determined by Griess
reagent and ELISA in supernatants, respectively (24 h). Values are expressed as means ± SEM of three independent experiments. *p < 0.05 (egpf plasmid
vs IL-32γ plasmid).
doi:10.1371/journal.pntd.0005413.g006
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as well as LL-37 peptide production were strongly increased when IL-32γ was overexpressed,
especially in infection with L. (V.) braziliensis (Fig 6D and 6E).
Discussion
The present study demonstrates the important role that endogenous IL-32γ plays in regulating
cytokines and microbicidal molecules induced by L. (L.) amazonensis or L. (V.) braziliensis in
THP-1-derived macrophages. Only IL-32γ mRNA was induced by parasites while splicing of
IL-32γ into IL-32β and IL-32α was observed after LPS stimulation. In fact, these data are in
accordance with previous results for LPS [7,42] and with our study showing that only IL-32γ
can be detected in cutaneous and mucosal lesions of patients infected with L. (Viannia) species
and in PBMCs cultured with L. (V.) braziliensis amastigotes [17].
Here, results indicate that L. (L.) amazonensis induces higher levels of IL-32γ mRNA and
IL-32 protein than L. (V.) braziliensis. IL-32 is intracellularly expressed, as detected in cell
lysates and confocal microscopy. It has been demonstrated that IL-32β can be driven towards
cell membrane in U937 human monocytic cell line during cell activation [43]. In our hands,
no specific IL-32 cell localization was detected in THP-1-derived macrophages during Leish-
mania species infection and it is not localized to parasite vacuoles in order to exert its biologi-
cal functions.
In this study, TNFα production was higher in macrophages infected with L. (L.) amazone-
nis than L. (V.) braziliensis. This result could not be ascribed to LPS contamination (S5 Fig).
Further, production of chemokine IL-8 was increased by both Leishmania species. We were
unable to detect IL-1β production in L. (L.) amazonenis-infected THP-1 macrophages. In
accordance, Shio et al. [44] demonstrated that L. (L.) mexicana, another species belonging to
the same subgenus of L. (L.) amazonensis, has the ability to inhibit NLRP3 inflammasome acti-
vation and subsequently reduces IL-1β secretion in PMA-differentiated THP-1 cells. In addi-
tion, in mouse macrophages IL-1β is not induced by L. (L.) amazonensis; however, in vivo IL-
1β is important to murine infection control [29]. In contrast to L. (L.) amazonensis, the present
study showed that besides TNFα induction, L. (V.) braziliensis induced IL-1β and induced
lower levels of IL-1Ra and IL-10 than L. (L.) amazonensis. This suggested a trend to more
inflammatory profile in L. (V.) braziliensis than in L. (L.) amazonensis infection. The produc-
tion of higher amounts of IL-1Ra and IL-10 in L. (L.) amazonensis-infected macrophages
could contribute to balancing the inflammatory process. It is known that macrophage has the
ability to produce inflammatory cytokines that is accompanied by an anti-inflammatory cyto-
kine profile contributing to homeostasis of the immune response [45]. In the case of Leish-
mania infection the suppression of immune response can also lead to less inflammatory
lesions or even to an anergic state in patients with severe cases of DCL caused by L. (L.) amazo-
nensis. Less inflammatory properties of L. (L.) amazonensis in comparison with L. (V.) brazi-
liensis have been described in mice [46] and human beings [21]. Thus, although in in vitro
model presented here, L. (L.) amazonensis induced higher levels of IL-32γ and TNFα than L.
(V.) braziliensis in human macrophages, the higher production of IL-10 and IL-1Ra induced
by L. (L.) amazonensis can be responsible by further control of inflammatory process and
immunosuppression in in vivo infections caused by this species. Nevertheless, we did not per-
form experiments to evaluate whether IL-10 or IL-1Ra can suppress the production of IL-32γ
or TNFα induced by Leishmania. In fact, there is no report about the control of IL-32 produc-
tion by anti-inflammatory cytokines. This point remains to be investigated.
One important point to be addressed is that, as reported above [21,47,48], it has been
described that L. (V.) braziliensis tends to lead a T-cell hypersensitivity pole (strong production
of IFNγ and TNFα) in patients with ML whereas L. (L.) amazonensis can lead to a T-cell
IL-32 in Leishmania macrophage infection
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hyposensitivity pole in patients with diffuse cutaneous leishmaniasis. However, both species
can cause localized cutaneous leishmaniasis without clinical differences in lesions or immune
responses [21] and there is no report about simultaneous comparison between cytokine pro-
ductions by human macrophages infected with these two species. In human monocytes/mac-
rophages from healthy donors the TNFα production after stimulation with L. (V.) braziliensis
is low unless IFNγ has been added [49,50]. In mouse models, L. (L.) braziliensis is more inflam-
matory than L. (L.) amazonensis [47,51], but lesions caused by this latter species are bigger
than those caused by L. (V.) braziliensis [46,52]. In addition, in mice L. (V.) braziliensis did not
cause ML. Thus, it could be a surprise that L. (L.) amazonensis is inducing higher production
of IL-32γ and TNFα in human THP-1 macrophages than L. (V.) braziliensis, but this could
depend on the macrophage origin or activation status. It is noteworthy that human beings
have IL-32 while mice lack this gene what can generate different responses when comparing
macrophages from humans or mice.
Previously, we had demonstrated [53] that TNFα is a potent inducer of IL-32 in human
synovial fibroblasts. Indeed, we now show that IL-32 protein production induced by Leish-
mania species and by LPS is also dependent on TNFα. On the other hand, IL-32γ upregulates
the production of proinflammatory cytokines such as TNFα, IL-1β and IL-8 [3]. We then rea-
soned that IL-32γ could be responsible for cytokine regulation during Leishmania sp infection.
Heinhuis et al. [41] demonstrated that IL-32γ is involved in cell death processes, and for this
reason the influence of overexpression of IL-32 in THP-1 cells was evaluated only for 24 h,
since after this time point, the increase of IL-32 inside the cells can lead to the cell death. After
infection with both Leishmania species, TNFα and IL-8 were down regulated in THP-1 cells
depleted of IL-32γ while overexpression of IL-32γ caused a strong increase in the production
of these cytokines. The high levels of TNFα induced after IL-32γ overexpression in L. (L.) ama-
zonensis infection are particularly noteworthy. Data from silencing (no effects on mRNA
TNFα levels after 4 h) and from overexpression of IL-32 (increase of mRNA TNFα) suggest
that the amount of IL-32γ can be a critical factor to increase transcription of TNFα. TNFα
induction capacity was one of the first properties described for IL-32 [4]. Moreover, IL-32γ
overexpression in THP-1 cells causes an increase in TNFα, IL-6 and IL-8 production [53] in
accordance with our results. Heinhuis et al. [53] demonstrated that in cells overexpressing
intracellular IL-32γ there is an enhanced TNFα mRNA stability, which explains higher TNFα
levels than in control cells. In fact, IL-32γ seems to be required to control TNFα mRNA stabil-
ity since in our hands silencing of IL-32γ decreased TNFα mRNA (24 h) whereas after overex-
pression of IL-32γ both TNFα mRNA (4 h) and TNFα protein were increased (24 h) in
comparison to control cells. These data further suggest that IL-32γ can influence post-tran-
scriptional mechanisms to increase TNFα during Leishmania species infection. We have previ-
ously reported increased expression of TNFα in lesions of ML patients infected with L.
(Viannia) species and described a positive correlation between levels of TNFα and IL-32 [17],
which is in agreement with these current data.
L. (V.) braziliensis-induced IL-1β and IL-1Ra as well as IL-10 induced by both Leishmania
species were not affected by the up or down regulation of IL-32γ. That IL-32γ had no effect on
IL-1β production was unexpected since silencing of IL-32 in THP-1 cells reduced TNFα, IL-8
and IL-1β after infection with MTB [6]. The negative regulator of IL-1β, IL-1Ra was induced
by L. (V.) brazilienis, however this induction was not affected by IL-32γ levels, thus suggesting
that IL-32γ is dispensable for IL-1β production but can enhance the effects of IL-1β during L.
(V.) braziliensis infection. By contrast, L. (L.) amazonensis does not induce IL-1β and the
induction of IL-1Ra by this parasite species was upregulated by IL-32γ, suggesting that if IL-1β
is induced in vivo it can be controlled by IL-1Ra in an IL-32γ-dependent manner. In accor-
dance, the induction of IL-1Ra by IL-32γ was described in PBMCs [45] and our data suggest
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that Leishmania parasites can partially subvert IL-32γ pro-inflammatory property by increas-
ing IL-1Ra.
Infected THP-1-derived macrophages inhibit Leishmania species growth but do not elimi-
nate them, at least until 48 h of culture. Cells depleted of IL-32 exhibited an increase in macro-
phage infection index after Leishmania species infection, which was reversed when IL-32γ was
overexpressed. These effects were related to alterations in the percentage of infected cells and
not to the number of parasites per cell. These results suggested that IL-32 is important to con-
trol infections caused by L. (L.) amazonensis and L. (V.) braziliensis in human macrophages.
Therefore, we evaluated microbicidal molecules known to be involved in Leishmania control
[30,54,55] as possible targets of IL-32γ. Our data demonstrate that IL-32γ is linked with the
induction of iNOS, cathelicidin and β-defensin 2 expression and consequently NO, LL-37 pep-
tide, and β-defensin 2 release during Leishmania species infection. These molecules were
induced by IL-32 in influenza virus [48] and MTB infection [8]. NO is a classical leishmanici-
dal molecule in mouse macrophages [30] but human macrophages produce low levels of NO.
Nevertheless, in some reports this was enough to contribute for Leishmania killing [56–58].
Cathelicidin plays a role in the control of lesions caused by L. (L.) amazonensis and prevents
parasite dissemination in mice [59]. Thus, while in mice NO and cathelicidin are important
molecules for anti-Leishmania macrophage activity in the absence of IL-32, in human cells
anti-microbial peptides dependent on IL-32γ can contribute to control Leishmania infection.
In our experiments, low levels of microbicidal molecules were detected in uninfected mac-
rophages, which decreased after IL-32 silencing (Fig 5). These results suggested that PMA used
to differentiate THP-1 cells into macrophages can induce low levels of IL-32 that, in turn, con-
tribute to induction of iNOS/NO and antimicrobial peptides. In fact, PMA can induce iNOS
[60] and IL-32 [36] in THP-1 cells, thus both can contribute to increase Leishmania-induced
microbicidal molecules.
Cathelicidin induction could be related to the IL-1Ra production, as described by Choi
et al. [61]. They reported that LL-37 or IL-32γ enhanced human macrophage IL-1Ra produc-
tion and subsequently led to the suppression of proinflammatory cytokines induced by IL-32γ
as a possible negative feedback mechanism. According to our data, since IL-32γ is linked to IL-
1Ra and LL-37 production after L. (L.) amazonensis infection, we suggest that IL-1Ra may
indeed play a role in the balance of the inflammatory state caused by L. amazonensis suggesting
a mechanism of feedback dependent on IL-32γ/LL-37/IL-1Ra.
In addition to the role of IL-32 in the production of microbicidal molecules we observed
that after 4 h of infection the percentage of infected macrophages was inversely associated with
IL-32 expression (Figs 5 and 6). As this is a short time for parasite proliferation, data suggest
that IL-32 can modulate the uptake of the parasites. As it was shown before that IL-32 can
induce differentiation of monocytes into macrophages increasing the phagocytosis capacity
[62], we are now investigating whether IL-32 can control the phagocytosis process of Leish-
mania sp.
Our study was focused in understanding the role of IL-32 in innate immune response by
evaluating human macrophage functions. However it is also known that IL-32 can drive the
acquired immune response by inducing the differentiation of monocytes into dendritic cells.
IL-32-matured and activated dendritic cells induce T helper (Th) lymphocyte differentiation
into Th1 and Th17 cells [63,64], which are important cells to control leishmaniasis [65]. The
role of IL-32-matured and activated dendritic cells must be further investigated in the context
of Leishmania sp infections.
In summary, we demonstrate that Leishmania species induce IL-32γ, and suggest that these
parasites can inhibit the IL-32γ splicing into the less pro-inflammatory isoforms IL-32β and
IL-32α. Furthermore, we demonstrated that during L. (V.) braziliensis and L. (L.) amazonensis
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infection IL-32γ was differentially associated with the production of pro and anti-inflamma-
tory mediators. In addition, IL-32γ upregulates the induction of microbicidal molecules,
which may contribute to control Leishmania species infections (S6 Fig). The results suggest
that IL-32γ is a crucial intracellular cytokine for the regulation of macrophage functions dur-
ing Leishmania species infection that can result in different consequences of clinical manifesta-
tions of leishmaniasis caused by L. (V.) braziliensis and L. (L.) amazonensis. Next steps will
include primary human macrophages to better understand the role of IL-32 in human leish-
maniasis. Our current knowledge concerning the role of IL-32 in ATL might be useful and
contribute to the development of new therapies.
Supporting information
S1 Table. ON-TARGETplus human IL-32 siRNA SMARTpool sequence.
(PDF)
S2 Table. Primers sequence.
(PDF)
S1 Fig. PMA-differentiated THP-1 cells (1x106 cells/mL) were infected with promastigote
forms (5x106 parasites) in stationary phase of growth of L. (L.) amazonensis (L. amaz),
metacyclic promastigote forms (5x106 parasites) of L. (V.) braziliensis (L. braz) or LPS (100
ng/mL) as a positive control during 4 h. Non-internalized parasites were washed out and
cells were incubated for 24 h or 48 h. (A) Time course production of IL-32γ after 4 h, 24 h and
48 h (left panel); Distribution of mRNA expression of isoforms of IL-32 after 24 h (right
panel); determined by quantitative real-time PCR. (B) TNFα cytokine production in 4 h-cul-
ture supernatant, by ELISA. (C) LDH levels were determined by Cytotox 96 assay in superna-
tants after 24 h. Values are expressed as means ± SEM of three independent experiments.
p< 0.05 (Medium vs LPS, L. amaz, L. braz).
(TIF)
S2 Fig. Time course of cytokine production induced by L. amazonensisand L. braziliensis
in PMA-differentiated THP-1 cells. PMA-differentiated THP-1 cells (2 x 105 cells/well) were
infected with promastigote forms (1 x 106 parasites) in the growth stationary phase of L. (L.)
amazonensis (L. amaz) and metacyclic promastigote forms (1 x 106 parasites) of L. (V.) brazi-
liensis (L. braz) during 4 h. Cells were washed to remove non-internalized parasites and incu-
bated for 24 h or 48 h. TNFα, IL-8, IL-1β, IL-1Ra and IL-10 concentrations were determined
by ELISA in culture supernatants after 4 h, 24 h and 48 h of incubation. Values are expressed
as means ± SEM of three independent experiments.
(TIF)
S3 Fig. PMA-differentiated THP-1 cells (2.5x106 cells/800 μL) were electroporated by
using Amaxa Nucleofector Technology with IL-32 siRNA (for IL-32 knockdown) and con-
trol siRNA and IL-32 plasmid (for IL-32 overexpression) and egfp plasmid (as a control)
according with protocol described in [28]. The final concentration of cells per well were 3 x
105 cells/100 μL. After 24 h of transfection, cells were infected with promastigote forms
(1.5x106 parasites) in growth stationary phase of L. (L.) amazonensis (L. amaz) or metacyclic
promastigote forms (1.5 x 106 parasites) of L. (V.) braziliensis (L. braz). Afterwards, non-inter-
nalized parasites were washed out and cells were incubated for 24 h. After 4 h (A and C) and
24 h (B and D) incubation, mRNA expression and protein levels of TNFα were determined by
quantitative real-time PCR and ELISA, respectively. Values are expressed as means ± SEM of
three independent experiments. p< 0.05 (Control SiRNA vs IL-32 SiRNA); (egpf plasmid vs
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IL-32γ plasmid); #p< 0.05 (L. amaz vs L. braz).
(TIF)
S4 Fig. PMA-differentiated THP-1 cells (2.5x106 cells/800 μL) were electroporated by
using Amaxa Nucleofector Technology with IL-32 siRNA (for IL-32 knockdown) and con-
trol siRNA according with protocol described in [38]. The final concentration of cells per
well were 3 x 105 cells/100 μL. After 24 h of transfection, cells were infected with promastigote
forms (1.5 x 106 parasites) in growth stationary phase of L. (L.) amazonensis (L. amaz) or meta-
cyclic promastigote forms (1.5 x 106 parasites) of L. (V.) braziliensis (L. braz). Afterwards, non-
internalized parasites were washed out and cells were incubated for 48 h. mRNA expression of
Il-32 all (left) and γ isoform of IL-32 (right) were determined by quantitative real-time PCR.
Values are expressed as means ± SEM of three independent experiments.
(TIF)
S5 Fig. Evaluation of LPS contamination in parasite cultures. PMA-differentiated THP-1
cells (2 x 105 cells/mL) were treated with polymyxin B (5 μg/mL) and infected with promasti-
gote forms (1 x 106 parasites) in the growth stationary phase and metacyclic promastigote
forms (1 x 106 parasites) of L. (V.) braziliensis (L. braz). After 4 h supernatants were collected
and cells were washed to remove non-internalized parasites and incubated for 24, 48 h in the
presence of polymyxin B. TNFα protein levels were determined by ELISA in supernatants.
Values are expressed as means ± SEM of three independent experiments. p< 0.05 (Medium
vs L. amaz, L. braz); #p< 0.05 (L. amaz vs L. braz).
(TIF)
S6 Fig. An overview of cytokines and microbicidal molecules induced by Leishmania spe-
cies in PMA-differentiated human THP-1 cells. IL-32γ and IL-8 are induced by L. (L.) ama-
zonensis and L. (V.) braziliensis at similar levels. L. (L.) amazonensis induces higher levels of
TNFα, IL-10 and IL-1Ra than L. (V.) braziliensis, which induces higher levels of IL-1β. TNFα
and IL-8 production is mediated by IL-32γ in infections caused by both species whereas IL-
1Ra production is only dependent on IL-32γ in L. (L.) amazonensis infection. In addition, L.
(V.) braziliensis–induced IL-1β is not dependent on IL-32γ as well as production of IL-10
induced by both parasite species. Considering microbicidal molecules IL-32γ contributes simi-
larly for their production in cells infected with both Leishmania species. The differential con-
trol of cytokines induced after L. (L.) amazonensis and L. (V.) braziliensis infections by IL-32γ
can contribute for different clinical outcomes of disease caused by theses parasites.
(TIF)
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